These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [NGAL: a biomarker of acute and chronic renal dysfunction]. Lalanne A; Beaudeux JL; Bernard MA Ann Biol Clin (Paris); 2011; 69(6):629-36. PubMed ID: 22123561 [TBL] [Abstract][Full Text] [Related]
29. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections. Barreto R; Elia C; Solà E; Moreira R; Ariza X; Rodríguez E; Graupera I; Alfaro I; Morales-Ruiz M; Poch E; Guevara M; Fernández J; Jiménez W; Arroyo V; Ginès P J Hepatol; 2014 Jul; 61(1):35-42. PubMed ID: 24613364 [TBL] [Abstract][Full Text] [Related]
31. Acute kidney injury in critically ill infants: the role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL). Mussap M; Degrandi R; Fravega M; Fanos V J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():70-2. PubMed ID: 20807163 [TBL] [Abstract][Full Text] [Related]
32. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Makris K; Markou N; Evodia E; Dimopoulou E; Drakopoulos I; Ntetsika K; Rizos D; Baltopoulos G; Haliassos A Clin Chem Lab Med; 2009; 47(1):79-82. PubMed ID: 19055468 [TBL] [Abstract][Full Text] [Related]
33. Neutrophil gelatinase-associated lipocalin, a new biomarker candidate in perfusate of machine-perfused kidneys: a porcine pilot experiment. Jochmans I; Monbaliu D; Pirenne J Transplant Proc; 2011 Nov; 43(9):3486-9. PubMed ID: 22099824 [TBL] [Abstract][Full Text] [Related]
34. [Biomarkers of acute kidney injury: a « trending topic » in cirrhosis]. Barreto R; Guevara M Gastroenterol Hepatol; 2013; 36(6):407-21. PubMed ID: 23711912 [TBL] [Abstract][Full Text] [Related]
35. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. de Geus HR; Bakker J; Lesaffre EM; le Noble JL Am J Respir Crit Care Med; 2011 Apr; 183(7):907-14. PubMed ID: 20935115 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal failure in hypertensives: a case-control study in a regional hospital in Ghana. Danquah M; Owiredu WKBA; Jnr BAE; Serwaa D; Odame Anto E; Peprah MO; Obirikorang C; Fondjo LA BMC Nephrol; 2023 Apr; 24(1):114. PubMed ID: 37101162 [TBL] [Abstract][Full Text] [Related]
37. Urinary NGAL in patients with and without acute kidney injury in a cardiology intensive care unit. Watanabe M; Silva GF; Fonseca CD; Vattimo Mde F Rev Bras Ter Intensiva; 2014; 26(4):347-54. PubMed ID: 25607262 [TBL] [Abstract][Full Text] [Related]
38. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women. Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561 [TBL] [Abstract][Full Text] [Related]
39. [Clinical implication of a novel biomarker Ngal in CKD]. Mori K; Mukoyama M; Kuwabara T; Kasahara M; Yokoi H; Nakao K Nihon Rinsho; 2009 Jun; 67(6):1233-41. PubMed ID: 19507520 [TBL] [Abstract][Full Text] [Related]
40. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*. Ricci Z; Netto R; Garisto C; Iacoella C; Favia I; Cogo P Pediatr Crit Care Med; 2012 Nov; 13(6):667-70. PubMed ID: 22895007 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]